Diagnostic Usefulness of Serum Hyaluronic Acid in Patients with SARS-CoV-2 Infection
Bogdan Cylwik, Kacper Gan, Marcin Kazberuk, Ewa Gruszewska, Anatol Panasiuk, Lech Chrostek · 2024
Read Diagnostic Usefulness of Serum Hyaluronic Acid in Patients with SARS-CoV-2 Infection by Bogdan Cylwik, Kacper Gan, Marcin Kazberuk, Ewa Gruszewska, Anatol Panasiuk, Lech Chrostek (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641923.txt.
Description
Bogdan Cylwik and co-authors tested whether a blood protein can flag how severe a COVID-19 case will get, in a 2024 study. The protein, hyaluronic acid, builds tissue scaffolding and rises when tissue is inflamed or harmed. The team measured it in eighty-seven patients and forty-five healthy controls. They then tracked how levels lined up with illness severity, oxygen needs, and survival.
Levels ran far higher in patients than in controls, and higher still in critical cases than in moderate ones. Patients on ventilators, those given steroids or immune therapy, and those hit by a cytokine storm all showed higher levels. Non-survivors carried more of the protein than survivors. As a test, it sorted critical illness and death risk with excellent accuracy. The authors propose it as an early warning marker for COVID-19 care.
Catalog record
| CREATOR | Bogdan Cylwik, Kacper Gan, Marcin Kazberuk, Ewa Gruszewska, Anatol Panasiuk, Lech Chrostek |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |